stockrowStryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) Net income
Stryker Corporation's net income for fiscal 2025 was $3.2B, up 8.45% from $3.0B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.6B. Over the past ten years it has ranged from $1.0B (fiscal 2017) to $3.6B (fiscal 2018); the current reading is higher than 91% of that period. Stryker Corporation ranks 3rd of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $3.2B | 8.45% |
| FY2024 | $3.0B | (5.43%) |
| FY2023 | $3.2B | 34.22% |
| FY2022 | $2.4B | 18.25% |
| FY2021 | $2.0B | 24.70% |
| FY2020 | $1.6B | (23.24%) |
| FY2019 | $2.1B | (41.37%) |
| FY2018 | $3.6B | 248.33% |
| FY2017 | $1.0B | (38.07%) |
| FY2016 | $1.6B | 14.45% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $753.0M | (40.99%) |
| Jun 2026 | $1.3B | 71.28% |
| Mar 2026 | $745.0M | (12.25%) |
| Dec 2025 | $849.0M | (1.16%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| ABT Abbott Laboratories compare | $5.4B |
| MDT Medtronic PLC compare | $5.3B |
| SYK Stryker Corporation | $3.6B |
| BSX Boston Scientific Corporation compare | $3.5B |
| GEHC GE HealthCare Technologies Inc. compare | $2.2B |
| PHG Koninklijke Philips N.V. compare | $1.1B |
| EW Edwards Lifesciences Corporation compare | $1.0B |
| DXCM DexCom, Inc. compare | $991.0M |
| STE STERIS plc compare | $829.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on SYK
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement